Immediate Impact
11 standout
Citing Papers
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Multiple myeloma
2024 Standout
Works of Robin Carson being referenced
Bortezomib, lenalidomide, and dexamethasone (VRd) ± daratumumab (DARA) in patients (pts) with transplant-eligible (TE) newly diagnosed multiple myeloma (NDMM): A multicenter, randomized, phase III study (PERSEUS).
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robin Carson | 193 | 152 | 133 | 33 | 243 | |
| Katarina Uttervall | 190 | 116 | 120 | 24 | 213 | |
| Katia Mancuso | 227 | 146 | 151 | 38 | 264 | |
| Serena Rocchi | 241 | 152 | 168 | 30 | 286 | |
| Christopher Strouse | 155 | 88 | 123 | 45 | 297 | |
| Christine Greil | 176 | 127 | 170 | 23 | 283 | |
| Sung-Soo Yoon | 89 | 73 | 93 | 31 | 204 | |
| Raphael Teipel | 131 | 70 | 55 | 21 | 185 | |
| Sung‐Soo Yoon | 146 | 88 | 118 | 51 | 260 | |
| Elizabeth H. Cull | 111 | 96 | 97 | 27 | 259 | |
| Alessandra Pompa | 168 | 89 | 100 | 23 | 239 |
All Works
Loading papers...